BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pereira JD, Tosatti JAG, Simões R, Luizon MR, Gomes KB, Alves MT. microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis. Biomedicine & Pharmacotherapy 2020;131:110709. [DOI: 10.1016/j.biopha.2020.110709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kawano I, Adamcova M. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1055911] [Reference Citation Analysis]
2 Sánchez-Sánchez R, Reinal I, Peiró-Molina E, Buigues M, Tejedor S, Hernándiz A, Selva M, Hervás D, Cañada AJ, Dorronsoro A, Santaballa A, Salvador C, Caiment F, Kleinjans J, Martínez-Dolz L, Moscoso I, Lage R, González-Juanatey JR, Panadero J, Aparicio-Puerta E, Bernad A, Sepúlveda P. MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats. Antioxidants (Basel) 2022;11:1955. [PMID: 36290678 DOI: 10.3390/antiox11101955] [Reference Citation Analysis]
3 Rosenfeld R, Riondino S, Formica V, Torino F, Martuscelli E, Roselli M. MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review. JPM 2022;12:1059. [DOI: 10.3390/jpm12071059] [Reference Citation Analysis]
4 Kastora SL, Pana TA, Sarwar Y, Myint PK, Mamas MA. Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis. Mol Diagn Ther 2022. [PMID: 35708889 DOI: 10.1007/s40291-022-00597-z] [Reference Citation Analysis]
5 Si Z, Zhong Y, Lao S, Wu Y, Zhong G, Zeng W. The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review. Front Oncol 2022;12:899145. [PMID: 35664800 DOI: 10.3389/fonc.2022.899145] [Reference Citation Analysis]
6 Jiang Y, Ghias K, Gupta S, Gupta A. MicroRNAs as Potential Biomarkers for Exercise-Based Cancer Rehabilitation in Cancer Survivors. Life (Basel) 2021;11:1439. [PMID: 34947970 DOI: 10.3390/life11121439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen L, Xu Y. MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review. Front Cardiovasc Med 2021;8:740515. [PMID: 34901206 DOI: 10.3389/fcvm.2021.740515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen D, Kelly C, Haw TJ, Lombard JM, Nordman IIC, Croft AJ, Ngo DTM, Sverdlov AL. Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers. Curr Heart Fail Rep 2021;18:362-77. [PMID: 34731413 DOI: 10.1007/s11897-021-00535-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sinitsky MY, Tsepokina AV, Khutornaya MV, Ponasenko AV, Sumin AN. Genetic basis of anthracyclines cardiotoxicity: Literature review. Acta biomedica scientifica 2021;6:27-38. [DOI: 10.29413/abs.2021-6.4.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khan P, Ebenezer NS, Siddiqui JA, Maurya SK, Lakshmanan I, Salgia R, Batra SK, Nasser MW. MicroRNA-1: Diverse role of a small player in multiple cancers. Semin Cell Dev Biol 2021:S1084-9521(21)00129-4. [PMID: 34034986 DOI: 10.1016/j.semcdb.2021.05.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li J, Peng D, Xie Y, Dai Z, Zou X, Li Z. Novel Potential Small Molecule-MiRNA-Cancer Associations Prediction Model Based on Fingerprint, Sequence, and Clinical Symptoms. J Chem Inf Model 2021;61:2208-19. [PMID: 33899462 DOI: 10.1021/acs.jcim.0c01458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Alves MT, Simões R, Pestana RMC, de Oliveira AN, Oliveira HHM, Soares CE, Sabino AP, Silva LM, Gomes KB. Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study. Immunol Invest 2021;:1-16. [PMID: 33557640 DOI: 10.1080/08820139.2021.1882486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]